Your browser doesn't support javascript.
loading
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
Morganti, Stefania; Tarantino, Paolo; Ferraro, Emanuela; D'Amico, Paolo; Viale, Giulia; Trapani, Dario; Duso, Bruno Achutti; Curigliano, Giuseppe.
Afiliação
  • Morganti S; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy.
  • Tarantino P; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy.
  • Ferraro E; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy.
  • D'Amico P; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy.
  • Viale G; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy.
  • Trapani D; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy.
  • Duso BA; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy.
  • Curigliano G; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@unimi.it.
Crit Rev Oncol Hematol ; 133: 171-182, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30661654

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Interpretação Estatística de Dados / Genômica / Medicina de Precisão / Sequenciamento de Nucleotídeos em Larga Escala / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Interpretação Estatística de Dados / Genômica / Medicina de Precisão / Sequenciamento de Nucleotídeos em Larga Escala / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália